Optimizing the dose of hydroxyurea therapy for patients with β-thalassemia intermedia (Hb E-β-thalassemia): a single center study from eastern India. (yeni pencere açar)

Bohara VV, Ray S, Chakrabarti P, Ray SS, Nath UK, Chaudhuri U.

Kaynak‎: Hemoglobin 2014;38(1):44-8.

İndeks‎: PubMed 24144212

DOI‎: 10.3109/03630269.2013.845844

https://www.ncbi.nlm.nih.gov/pubmed/24144212 (yeni pencere açar)

Hydroxyurea in thalassemia intermedia--a promising therapy. (yeni pencere açar)

Dixit A, Chatterjee TC, Mishra P, Choudhry DR, Mahapatra M, Tyagi S, Kabra M, Saxena R, Choudhry VP.

Kaynak‎: Ann Hematol 2005;84(7):441-6.

İndeks‎: PubMed 15838670

DOI‎: 10.1007/s00277-005-1026-4

https://www.ncbi.nlm.nih.gov/pubmed/15838670 (yeni pencere açar)

Effect of hydroxyurea on the transfusion requirements in patients with severe HbE-beta-thalassaemia: a genotypic and phenotypic study. (yeni pencere açar)

Italia KY, Jijina FF, Merchant R, Panjwani S, Nadkarni AH, Sawant PM, Nair SB, Ghosh K, Colah RB.

Kaynak‎: J Clin Pathol 2010;63(2):147-50.

İndeks‎: PubMed 20154037

DOI‎: 10.1136/jcp.2009.070391

https://www.ncbi.nlm.nih.gov/pubmed/20154037 (yeni pencere açar)

Echocardiographic finding in beta-thalassemia intermedia and major: absence of pulmonary hypertension following hydroxyurea treatment in beta-thalassemia intermedia. (yeni pencere açar)

Karimi M, Borzouee M, Mehrabani A, Cohan N.

Kaynak‎: Eur J Haematol 2009;82(3):213-8.

İndeks‎: PubMed 19077048

DOI‎: 10.1111/j.1600-0609.2008.01192.x

https://www.ncbi.nlm.nih.gov/pubmed/19077048 (yeni pencere açar)

Effect of combination therapy of hydroxyurea with l-carnitine and magnesium chloride on hematologic parameters and cardiac function of patients with beta-thalassemia intermedia. (yeni pencere açar)

Karimi M, Mohammadi F, Behmanesh F, Samani SM, Borzouee M, Amoozgar H, Haghpanah S.

Kaynak‎: Eur J Haematol 2010;84(1):52-8.

İndeks‎: PubMed 19799627

DOI‎: 10.1111/j.1600-0609.2009.01356.x

https://www.ncbi.nlm.nih.gov/pubmed/19799627 (yeni pencere açar)

Reduction of the clinical severity of sickle cell/beta-thalassemia with hydroxyurea: the experience of a single center in Greece. (yeni pencere açar)

Loukopoulos D, Voskaridou E, Kalotychou V, Schina M, Loutradi A, Theodoropoulos I.

Kaynak‎: Blood Cells Mol Dis 2000;26(5):453-66.

İndeks‎: PubMed 11112383

DOI‎: 10.1006/bcmd.2000.0328

https://www.ncbi.nlm.nih.gov/pubmed/11112383 (yeni pencere açar)

Fetal globin stimulant therapies in the beta-hemoglobinopathies: principles and current potential. (yeni pencere açar)

Perrine SP.

Kaynak‎: Pediatr Ann 2008;37(5):339-46.

İndeks‎: PubMed 18543545

https://www.ncbi.nlm.nih.gov/pubmed/18543545 (yeni pencere açar)

Single and combination drug therapy for fetal hemoglobin augmentation in hemoglobin E-beta 0-thalassemia: Considerations for treatment. (yeni pencere açar)

Singer ST, Kuypers FA, Olivieri NF, Weatherall DJ, Mignacca R, Coates TD, Davies S, Sweeters N, Vichinsky EP.

Kaynak‎: Ann N Y Acad Sci 2005;1054:250-6.

İndeks‎: PubMed 16339672

DOI‎: 10.1196/annals.1345.031

https://www.ncbi.nlm.nih.gov/pubmed/16339672 (yeni pencere açar)

Treatment of beta-thalassemia patients with recombinant human erythropoietin: effect on transfusion requirements and soluble adhesion molecules. (yeni pencere açar)

Chaidos A, Makis A, Hatzimichael E, Tsiara S, Gouva M, Tzouvara E, Bourantas KL.

Kaynak‎: Acta Haematol 2004;111(4):189-95.

İndeks‎: PubMed 15153710

DOI‎: 10.1159/000077551

https://www.ncbi.nlm.nih.gov/pubmed/15153710 (yeni pencere açar)

Efficacy of erythropoietin on dialysis in patients with beta thalassemia minor. (yeni pencere açar)

Di Iorio B, De Nicola L, Bellizzi V, Minutolo R, Zamboli P, Rubino R, Fuiano G, Conte G.

Kaynak‎: Blood Purif 2004;22(5):453-60.

İndeks‎: PubMed 15359104

DOI‎: 10.1159/000080729

https://www.ncbi.nlm.nih.gov/pubmed/15359104 (yeni pencere açar)

The role of recombinant human erythropoietin in the treatment of thalassemia. (yeni pencere açar)

Rachmilewitz EA, Aker M.

Kaynak‎: Ann N Y Acad Sci 1998;850:129-38.

İndeks‎: PubMed 9668535

https://www.ncbi.nlm.nih.gov/pubmed/9668535 (yeni pencere açar)

Darbepoetin alfa for the treatment of anaemia in alpha- or beta- thalassaemia intermedia syndromes. (yeni pencere açar)

Singer ST, Vichinsky EP, Sweeters N, Rachmilewitz E.

Kaynak‎: Br J Haematol 2011;154(2):281-4.

İndeks‎: PubMed 21496003

DOI‎: 10.1111/j.1365-2141.2011.08617.x

https://www.ncbi.nlm.nih.gov/pubmed/21496003 (yeni pencere açar)

The emerging role of fetal hemoglobin induction in non-transfusion-dependent thalassemia. (yeni pencere açar)

Thein SL.

Kaynak‎: Blood Rev 2012;26 Suppl 1:S35-9.

İndeks‎: PubMed 22631042

DOI‎: 10.1016/S0268-960X(12)70011-5

https://www.ncbi.nlm.nih.gov/pubmed/22631042 (yeni pencere açar)